Bengaluru: A 33-year-old man, who was participating in a clinical trial, died at his brother's house in Bahubali Nagar, Jalahalli, off Tumakuru Road o.

Competition in the ever-growing market for obesity treatments continues to mount, with positive early data for Hong Kong’s ...

While scientists still aren’t sure how phosphine wreaks so much havoc on the body, some are developing medications that can help mitigate the harm it causes.

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Amneal Pharmaceuticals (AMRX) announced that the FDA has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...

The NPI-001 (N-acetylcysteine amide) tablets are a proprietary investigational therapy for the treatment of patients with ...

On January 10, 2025, the US Court of Appeals for the Federal Circuit issued a precedential opinion in Novartis Pharmaceuticals Corp. v. Torrent ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Spektus Pharma, a Quebec-based specialty pharma company developing therapeutics for the treatment of CNS disorders, has ...

Imexpharm Corporation has announced its 2024 financial results with net revenue reaching VND2,205 billion, up 10.6 percent year on year, driven by robust growth in ETC channel and high-quality ...

The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.

Akums Drugs and Pharmaceuticals share price slumped 6.57 per cent at Rs 585 a piece on the BSE in Wednesday's intraday trade ...